COVID-19 Clinical Trials
Clinical trials help researchers develop new and better treatments. The information they provide is the only way for medical breakthroughs to reach the public. During the current COVID-19 pandemic, it’s vital that patients and healthy volunteers participate in research related to the virus and its effects on our physical and mental health.
At this time, we invite to you open a profile through MyChart so that we are able to know your preferred areas of interest so our recruitment team may contact you with trials as they become available.
If you have questions or concerns, please contact us at helpusdiscover@yale.edu or call 1-877-978-8343.
COVID-19 Clinical Trials
- Diseases of the Nervous SystemEvaluating the Immune Response to COVID-19 Vaccination in B-cell Depleted PatientsPrincipal Investigator: Erin Longbrake
- COVID-19 Inpatient, COVID-19 OutpatientA Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of Aprepitant Injectable Emulsion in Early Hospitalized Adult Patients with COVID-19Principal Investigator: Zyad Carr
- Infectious Diseases, COVID-19 Inpatient, COVID-19 OutpatientPneumococcal Epidemiology Study covidPrincipal Investigator: Daniel Weinberger
- Women's Health, COVID-19 Inpatient, COVID-19 OutpatientI-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill PatientsPrincipal Investigator: Jon Koff
- Tobacco Addiction, COVID-19 Inpatient, COVID-19 OutpatientPerinatal Attentional Retraining Intervention for Smoking (PARIS) covidPrincipal Investigator: Ariadna Forray